2017

Civil Air Patrol members from around the state participated in a multi-day training exercise this past weekend, beginning The Pierce County Airport-Thun Field (PLU) in Puyallup, WA, served as the mission base, while five remote staging areas were activated across the state including Yakima, Spokane, Walla Walla, Bellingham, and Vancouver. According to Colonel James Furlong, […]

by

New research suggests that the cannabis-extract cannabidiol could help treat autism. Autism is challenging to treat pharmacologically because there’s no single cause. Autism can be caused by genetic factors, environmental factors (e.g., pesticide exposure) or a combination of both. Depending on the underlying cause, the severity of symptoms ranges across a spectrum, thus leading to […]

by

According to a forecast report by Arcview Market Research, growth in the legal cannabis market will re-accelerate in the beginning of 2018, as adult use (recreational use) sales are expected to ramp up in Canada, California, and Massachusetts along with medical sales in Florida. The market is expected to grow from the $6.7 billion market […]

by

According to a report by New Frontier Data, medical cannabis sales in 2017 are forecast to grow to $5.3 billion, which is 67% of total cannabis sales. The report projects that by 2025, medical sales in current legal states are forecast to grow to $13.2 billion, which will account for 55% of total cannabis sales. Adult use […]

by

OVERLAND PARK, Kan.–(BUSINESS WIRE)–Vince Associates will conduct an inpatient clinical trial on the psychological effects of an active ingredient in marijuana — cannabidiol — in support of a federal collaboration seeking to better understand the abuse potential of the substance. Vince Associates was awarded a research subcontract valued at $2.8 million from Leidos Biomedical Research […]

by

Vitality Biopharma Inc (OTCMKSTS:VBIO) is a stock that should be followed closely. The stock price has been somewhat static between March 2017 and September 2017, after a fall in price from $4 to $1.5 between December 2016 and January 2017. The stock’s price movement is shown in the graph below: VBIO Daily Chart Between March […]

by

OVERLAND PARK, Kan.–(BUSINESS WIRE)–Vince Associates will conduct an inpatient clinical trial on the psychological effects of an active ingredient in marijuana — cannabidiol — in support of a federal collaboration seeking to better understand the abuse potential of the substance. Vince Associates was awarded a research subcontract valued at $2.8 million from Leidos Biomedical Research […]

by

Treatment with cannabidiol reduces some major symptoms in mice with a genetic condition recapitulating Dravet syndrome, a devastating childhood brain disorder. Cannabidiol is a non-intoxicating substance among the several active compounds derived from Cannabis plants. This molecule can also be produced synthetically. The results of its use to treat Dravet syndrome are reported in the […]

by

The effects of vaporized cannabis on symptoms associated with chronic obstructive pulmonary disease (COPD) are the target of a new clinical trial that stems from a partnership between medical cannabis products company Tilray and the Research Institute of the McGill University Health Centre (RI-MUHC) in Montreal, Canada. The company estimates that 45–90% of adults with advanced COPD suffer […]

by

According to a research published by Ameri Research Inc., the global legal cannabis market was valued at $14.3 billion in 2016. The market is forecast to grow at a CAGR of 21.1% between 2017 and 2024, while reaching a value of $63.5 billion in global sales in 2024. The rising demand of cannabis for recreational […]

by

TORONTO, ONTARIO–(Marketwired – Sept. 27, 2017) – Revive Therapeutics Ltd. (“Revive” or the “Company”) (TSX VENTURE:RVV) (OTCQB:RVVTF), a company focused on the research, development and commercialization of novel treatments for serious and unmet medical needs, today announced that it has submitted an application to the U.S. Food and Drug Administration (“FDA”) seeking orphan drug designation […]

by

So what’s the next best contender? According to research, cannabis. A 2013 study published in the Journal of Substance Use Misuse found that people were self-medicating, in order to deal with and manage hyperactivity and impulsive — two major components of ADD/ADHD. The study surveyed about 280 cannabis users and the main finding was that a […]

by

She had no clue what she was in for, but certainly couldn’t have imagined this. Ellie Reid, a 26-year-old graduate student at the University of North Carolina at Chapel Hill, had one of the worst nights of her life—and all she did was eat a weed brownie. “I had no sense of the time. I […]

by

By Alicia Wallace, The Cannabist Staff Cannabidiol is a non-psychoactive cannabis compound touted for its medicinal promise — but marijuana- and hemp-derived extracts rich in CBD and low in intoxicating THC are facing a future yet to be determined. The Cannabist’s special report “CBD, TBD” explores the issues with CBD — federal-state conflicts, national drug […]

by